Methyl 2-formylnicotinate

Catalog No.: 
ACDRMI964
CAS No.: 
25230-59-5
Molecular Formula: 
C8H7NO3
Molecular Weight: 
165.15
Methyl 2-formylnicotinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$81.00In stockInquiry
250mg95%$117.00In stockInquiry
1g95%$286.00In stockInquiry
5g95%$1001.00In stockInquiry
10g95%$1601.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-formylnicotinate
IUPAC Namemethyl 2-formylnicotinate
Molecular FormulaC8H7NO3
Molecular Weight165.15
SMILESO=C(OC)C1=C(C=O)N=CC=C1
InChI KeySPCNFHHJOBSFFV-UHFFFAOYSA-N
SynonymMethyl 2-formylnicotinate;2-formyl-3-Pyridinecarboxylic acid methyl ester;2-Formyl-nicotinic acid methyl ester;3-Pyridinecarboxylic acid, 2-formyl-, methyl ester;Methyl 2-formylpyridine-3-carboxylate
CAS No.25230-59-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDRMI964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIFBX327 route compound structure diagram
    ACIFBX32740134-18-7In Stock
  4. Then
  5. ACDRMI964 route product structure diagram
    ACDRMI96425230-59-5In Stock
Inquiry

2. ACDRMI964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJCMQ945 route compound structure diagram
    ACJCMQ94593-60-7In Stock
  4. Then
  5. ACDRMI964 route product structure diagram
    ACDRMI96425230-59-5In Stock
Inquiry

3. ACDRMI964 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDRMI964 route product structure diagram
    ACDRMI96425230-59-5In Stock
Inquiry

Comments (0)